ANTIBODY RESPONSES TO ANTIGENIC DETERMINANTS OF INFLUENZA VIRUS HEMAGGLUTININ

Mice immunized sequentially with two related influenza virus hemagglutinins (HA) produced a secondary antibody response with two different specificities. Some antibodies were specific for determinants common to both HA's. Paradoxically, some antibodies were directed to determinants existing only in the HA first encountered. Primed spleen cells treated with anti-θ serum and complement were transferred from animals immunized with the first HA to either normal, irradiated, or thymus-deprived recipients. These memory cells were boosted in the recipients with either the homologous or the heterologous cross-reacting HA. B-memory lymphocytes were shown to be directly triggered by both HA's and to be able to secrete, independently of T lymphocytes, antibodies to both kinds of determinants. However, T cells were shown to modulate this secondary response by either enhancing or suppressing antibody secretion by B-memory cells, depending on experimental conditions. These results are discussed in terms of antigen recognition by B cells and of kinetics of development of immunological memory.

[1]  J. Kappler,et al.  Regulation of the immune response. II. Qualitative and quantitative differences between thymus- and bone marrow-derived lymphocytes in the recognition of antigen. , 1973 .

[2]  M. Morita,et al.  Antigenic memory in man in response to sequential infections with influenza A viruses. , 1972, The Journal of infectious diseases.

[3]  N. Klinman,et al.  OVERLAP STIMULATION OF PRIMARY AND SECONDARY B CELLS BY CROSS-REACTING DETERMINANTS , 1973, The Journal of experimental medicine.

[4]  R. Webster,et al.  DISQUISITIONS ON ORIGINAL ANTIGENIC SIN : II. PROOF IN LOWER CREATURES , 1966 .

[5]  N. Sinclair REGULATION OF THE IMMUNE RESPONSE , 1969, The Journal of Experimental Medicine.

[6]  E. Sercarz,et al.  The asynchronous development of immunological memory in helper (T) and precursor (B) cell lines , 1971, European journal of immunology.

[7]  R. Webster,et al.  Disquisitions of Original Antigenic Sin. I. Evidence in man. , 1966, The Journal of experimental medicine.

[8]  M. Raff,et al.  The carrier effect in the secondary response to hapten‐protein conjugates. II. Cellular cooperation , 1971, European journal of immunology.

[9]  M. Cramer,et al.  CROSS-STIMULATION OF MONOCLONAL ANTIBODIES IN ANAMNESTIC RESPONSES , 1973, The Journal of experimental medicine.

[10]  H. Wigzell,et al.  IMMUNE RESPONSES AGAINST NATIVE AND CHEMICALLY MODIFIED ALBUMINS IN MICE , 1972, The Journal of experimental medicine.

[11]  J. Ivanyi,et al.  Recall of antibody synthesis to the primary antigen following successive immunization with heterologous albumins. A two‐cell theory of the original antigenic sin , 1972, European journal of immunology.

[12]  A. Bussard,et al.  Original antigenic sin at the cellular level. II. Specificity of the antibodies produced by individual cells , 1973, European journal of immunology.

[13]  Thomas Francis,et al.  EPIDEMIOLOGIC AND IMMUNOLOGIC SIGNIFICANCE OF AGE DISTRIBUTION OF ANTIBODY TO ANTIGENIC VARIANTS OF INFLUENZA VIRUS , 1953, The Journal of experimental medicine.

[14]  A. Allison,et al.  ANTIBODY RESPONSES TO ANTIGENIC DETERMINANTS OF INFLUENZA VIRUS HEMAGGLUTININ , 1974, The Journal of experimental medicine.

[15]  W. Dowdle,et al.  Antigenic variation in current human type A influenza viruses: antigenic characteristics of the variants and their geographic distribution. , 1973, Bulletin of the World Health Organization.

[16]  Sylvia Deutsch,et al.  Original antigenic sin at the cellular level I. Antibodies produced by individual cells against cross‐reacting haptens , 1972, European journal of immunology.

[17]  R. Gilden,et al.  Antibody responses after successive injections of related antigens. , 1963, Immunology.

[18]  N. Warner,et al.  Blocking of the Lymphocyte Antigen Receptor Site with Anti-immunoglobulin Sera in vitro , 1970, Nature.

[19]  R. Webster,et al.  DISQUISITIONS ON ORIGINAL ANTIGENIC SIN , 1966, The Journal of experimental medicine.